CRCA bid-ask spread and liquidity

ProShares Ultra CRCL

LeverageProShares$109m net assets0.95% fee

As of Oct 22, 2026, CRCA’s median bid-ask spread over 30 days was 0.55%, and its IQ Liquidity Score is 59, Liquid with care.

Overview Holdings Dividends Trading Flows Compare

IQ Liquidity Score

5 of 6 measured · Oct 22, 2026

Liquid with care13th percentile of 107 leverage ETFs

0 · Hard to trade100 · Trades like a giant

The IQ Liquidity Score: a fixed 0 to 100 scale of trading conditions, the same anchors for every fund; 100 is the easiest to trade. It measures how cheaply and reliably the fund trades, not whether to own it. Method →

Liquid with care: its typical spread is 0.55% of its price.

Ask IQ about this page

Ask IQ about CRCA bid-ask spread and liquidity

Answers cite the figures on this page.

Cost to trade

0.55% median spread, 30 days to Oct 22, 2026

28.0

Capacity

Holdings can absorb $40m a day, Oct 22, 2026

53.4

Price fidelity

95% of days within ±0.60% of NAV, 249 days to Oct 22, 2026

64.5

Primary market

12 active dealers of 39; largest 34% of creations and redemptions, N-CEN to May 31, 2026

100.0

Bad-day behaviour

Premium 0.9427× normal on the 10 worst S&P 500 days, to Oct 22, 2026

100.0

Depth

Not measured · needs trade and quote data (Phase 2)

Cost for your order

One way, half its 30-day median spread; sizes above $10,000 are estimates

CRCA: cost for your order at each size, round trip
Order	Dollars	Percent	Basis
$1,000	$2.75	0.28%	spread
$10,000	$28	0.28%	spread
$100,000	$882	0.88%	estimate
$1,000,000	$21,942	2.19%	estimate

Spread 0.55% median, 30 days to Oct 22, 2026. Above $10,000 the cost adds an estimate of market impact that grows with the order against the holdings’ capacity; a patient limit pays less.

Full cost to own

At $10,000

1 year

1.73%$173

fee alone 0.95% · $95

5 years

5.53%$553

fee alone 4.75% · $475

Fee, plus the round-trip spread once, plus the median premium paid at entry.

Premium or discount to value

Daily, 249 days to Oct 22, 2026 · the ±1% band marked

Latest close, Oct 22

+0.17%

95% of days within

±0.60%

Days more than 1% from NAV

2 of 249

Widest

−1.29%, May 8, 2026

Close against the NAV its issuer struck the same day, from the issuer. Source: ETFIQ.

Capacity

What the holdings can absorb a day, at 10% of each one’s volume

Holdings can absorb

$40m

CRCA’s holdings can absorb $40m a day, measured on the trading volume of CRCL, the asset its multiple is on, divided by its multiple of 2, as of Oct 22, 2026. A $1m order is 2.51% of a day’s capacity.

The holding that sets the limit: CRCL (CRCL), $798m a day traded, the median of 20 days to Oct 22, 2026. Capacity is the least of the holding-level ratios over the holdings making up 95% of the weight.

Dealers

Authorized participants · N-CEN, the year to May 31, 2026

Active dealers

of 39 authorized

Largest

34%

of creations and redemptions

One dealer

12 active

12 of 39 authorized participants created or redeemed CRCA shares in the year to May 31, 2026. From the fund’s Form N-CEN, filed Aug 14, 2026.

The active authorized participants, largest first, by share of the dollars created and redeemed: Merrill Lynch, Pierce, Fenner and Smith Incorporated (33.7%), Jane Street Capital, LLC (22.6%), Virtu Americas LLC (15.6%), ABN AMRO Clearing USA LLC (13.3%), Goldman Sachs & Co. LLC (9.3%), J.P. Morgan Securities LLC (4.3%), BofA Securities, Inc. (0.3%), Mirae Asset Securities (USA) Inc. (0.3%), Citigroup Global Markets Inc. (0.2%), National Financial Services LLC (0.2%), UBS Securities LLC (0.2%), Barclays Capital Inc. (0.0%). 27 more were listed and created or redeemed nothing.

Creations and redemptions

By week, 52 weeks to Oct 22, 2026

Oct 27 2025Each week’s net creations (green) and redemptionsOct 22 2026

$376m net created in 34 weeks and $192m net redeemed in 18, over the 52 weeks from Oct 27, 2025 to Oct 22, 2026, from the change in its shares outstanding.

How to trade CRCA

To buy or to sell, up to $100,000

Order type: Limit: midpoint + 6¢ to buy, midpoint − 6¢ to sell.At the Oct 22 close of $18.67, that’s $18.73 to buy and $18.61 to sell.
When: ETF spreads are usually widest in the first minutes after the open and the last before the close.
Size: Up to $398,986 is 1% of what its holdings can absorb in a day, for a buy or a sell.
Watch: The premium. On 95% of days it is within ±0.60%; beyond that a buyer pays more, and a seller gets less, than the holdings are worth.

Phase 2 · drawn now, filled when trade data arrives

Spread through the dayComing with trade data

Median spread by half hour, 30 days.

Buyers against sellersComing with trade data

Share of volume at the ask against at the bid.

Retail flow, estimatedComing with trade data

Sub-penny prints as a share of volume.

Large tradesComing with trade data

Prints above $500k, count and share.

Closing auctionComing with trade data

Share of the day’s volume at the close.

Questions people ask

Is CRCA liquid?

CRCA’s IQ Liquidity Score is 59 of 100, Liquid with care, the 13th percentile of 107 leverage ETFs, as of Oct 22, 2026. Its holdings can absorb $40m a day.

What is CRCA’s bid-ask spread?

0.55% of the midpoint, the median over the 30 days to Oct 22, 2026, as its issuer states it. Half of it is about 6¢ a share at the Oct 22 close.

Does CRCA trade at a premium or discount to NAV?

It closed +0.17% from its NAV on Oct 22, 2026. On 95% of the 249 days to then it was within ±0.60%, and it closed more than 1% from NAV on 2 of them.

Who is the AP for CRCA?

CRCA’s latest Form N-CEN, for the period ending May 31, 2026, lists 39 authorized participants (APs), and 12 created or redeemed shares. The largest were Merrill Lynch, Pierce, Fenner and Smith Incorporated (33.7%), Jane Street Capital, LLC (22.6%), Virtu Americas LLC (15.6%) of the dollars its APs created and redeemed.

Who is the LMM for CRCA?

CRCA’s lead market maker (LMM) on NYSE Arca is Virtu Americas LLC. Lead market maker per NYSE Arca, as of Oct 23, 2026.

What does it cost to trade $10,000 of CRCA?

About $28 one way, 0.28%: half its 30-day median spread. In and out costs twice that. Owning $10,000 for a year costs about $173 all in, against $95 for the fee alone.

How do I place a limit order for CRCA?

Set the limit at the midpoint + 6¢ to buy, or the midpoint − 6¢ to sell, in your broker’s quote. At the Oct 22 close of $18.67, that’s $18.73 to buy and $18.61 to sell.

Sources and dates

SpreadProShares (fund page), 30-day median · to Oct 22, 2026

Premium to NAVETFIQ, close against the issuer’s NAV · Oct 23, 2025 to Oct 22, 2026

CapacityETFIQ, each holding’s 20-day median dollar volume · to Oct 22, 2026

DealersForm N-CEN · the year to May 31, 2026

Creations and redemptionsShares outstanding, daily, from the issuer

IQ Liquidity ScoreETFIQ · Oct 22, 2026

Where to next

ETF trading costs and liquidity→Cost-to-trade checker→Why low volume does not mean illiquidguide →Limit orders vs market orders for ETFsguide →How the IQ Liquidity Score is builtmethod →CRCA fund page→

Cite this pageCitation, APA and Markdown

ETFIQ, CRCA trading: cost, capacity, premium and dealers, data as of Oct 22, 2026. https://etfiq.com/funds/crca/trading/

Open data →

The score measures trading conditions, not the fund. ETFIQ makes no recommendations.